Search results for 810

APC/Fire™ 810 anti-human CD4 Antibody, IFN-γR b chain, SK3, BioLegend, 344661

APC/Fire™ 810 anti-human CD4 Antibody, IFN-γR b chain, SK3, BioLegend, 344662

PE/Fire™ 810 anti-human CD223 (LAG-3) Antibody, CD223 (LAG-3), 7H2C65, BioLegend, 369223

The staining of clone 7H2C65 cannot be blocked by clone 11C3C65, which is another anti-human CD223 (LAG-3) antibody.

PE/Fire™ 810 anti-human TCR γ/δ Antibody, TCR γ/δ, B1, BioLegend, 331243

Clone B1 is also known as clone B1.1.Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections3and paraffin-embedded sections5,in vitroblocking, and spatial biology (IBEX)8,9. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for highly sensitive assays (Cat. Nos. 331235 and 331236).

APC/Fire™ 810 anti-human TCR α/β Antibody, TCR α/β, IP26, BioLegend, 306749

Additional reported applications (for the relevant formats) include: T cell activation. When co-staining with anti-CD3, we recommend using clone UCHT1, since we have confirmed that IP26 does not compete with this clone. Other anti-CD3 clones may compete out the binding of IP26.

APC/Fire™ 810 anti-human TCR α/β Antibody, TCR α/β, IP26, BioLegend, 306750

Additional reported applications (for the relevant formats) include: T cell activation. When co-staining with anti-CD3, we recommend using clone UCHT1, since we have confirmed that IP26 does not compete with this clone. Other anti-CD3 clones may compete out the binding of IP26.

APC/Fire™ 810 anti-human CD274 (B7-H1,PD-L1) Antibody, CD274, MIH3, BioLegend, 374515

Additional reported applications (for the relevant formats) include blocking1, 2.Clone MIH3 blocks the binding of PD-L1 with PD-1 , but did not block the binding of PD-L1 with B7-1 (CD80).

APC/Fire™ 810 anti-human CD274 (B7-H1,PD-L1) Antibody, CD274, MIH3, BioLegend, 374516

Additional reported applications (for the relevant formats) include blocking1, 2.Clone MIH3 blocks the binding of PD-L1 with PD-1 , but did not block the binding of PD-L1 with B7-1 (CD80).

APC/Fire™ 810 anti-mouse/human CD45R/B220 Antibody, CD45R/B220, RA3-6B2, BioLegend, 103277

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1,in vitroandin vivomodulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

APC/Fire™ 810 anti-mouse/human CD45R/B220 Antibody, CD45R/B220, RA3-6B2, BioLegend, 103278

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1,in vitroandin vivomodulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.